Searched for
INDIA BRANDS AND PATENTS
- India attracts capital. Now it must build what the world pays royalties forIndia has emerged as a major investment destination, but much of the value generated by foreign companies still flows overseas through divi...
India-designed mobile phones likely in 10-14 months under MPMS; no place for copycats: Ashwini VaishnawNew indigenously designed mobile phones with Indian IP rights will launch in 10-14 months. The government will strictly screen brands, prev...- Ladoos, pedas sold as Ayodhya Ram Mandir Prasad found fake: Consumer body fines Amazon for misleading ads; says devotees' religious sentiments exploitedLadoos, pedas, and other sweets sold on Amazon as Ayodhya Ram Mandir Prasad without any temple authorisation have landed the e-commerce gia...
- No plastic, only coconut leaves: Bengaluru Christ University professor builds Rs 70 crore business by making eco-friendly straws, products are exported to 25 countriesFollowing a chance discovery, an English professor at Christ University in Bengaluru has pioneered eco-friendly, plastic-free straws made f...
- Nestle looks to develop new products to serve users of weight-loss drugsNestle is developing specialized products for GLP-1 weight-loss drug users. Artificial intelligence aids in analyzing research and identify...
- Chemical sector: Although long, there is a way around China trouble; combine 20 stocks to get your portfolio’s chemistry rightFor the chemicals sector, it all depends on a transformation that is still unfolding and will take years to play out. Backward-integration ...
- Bengaluru-based chip company Level Five Cartronics seeks OSAT partners in IndiaThe company has held discussions with Indian OSAT companies including CG Semi, and Kaynes Semicon in Sanand, and Suchi Semicon in Surat, as...
- Swadeshi 1.0 vs. Made in India 2.0: How India turned a 1905 boycott into a 2026 business strategyIndependence Day 2026: From the Swadeshi movement to Atmanirbhar Bharat. Early Swadeshi movements fostered indigenous industries against im...
- Our service business gave us the insight to build better products: Urban Company's Varun KhaitanUrban Company has launched its Native M3 and Native M3 Pro water purifiers with a three-year unconditional warranty and no routine servicin...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of more than 23%Market breadth (always a better indicator of the underlying sentiment) has remained positive for a few trading sessions in a row. This is w...
- Dhoot, Milky Mist or Molbio? What should investors pick in Rs 7,000 crore IPO rush this weekThis week, India's IPO market shines brightly as five firms successfully raise over Rs 7,000 crore. Analysts highlight Dhoot Transmission a...
- Aretto targets 100 retail touchpoints as India kids’ footwear brand plots global expansionAretto targets over 100 retail touchpoints by fiscal 2027. The Indian kids' footwear brand is shifting to omnichannel and international mar...
- Independence Day 2026: India, which once couldn't make smallpox vaccine, has now crossed a pharma milestone the world can't ignore2026 Independence Day: India's pharmaceutical industry marks a historic milestone with a new drug approval. This achievement reflects decad...
- Picking the right pharma stock is getting harder; so pick a portfolio: 20 stocks with -23% to +22% downside to upside potentialFor Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...
- IP protection, FTA utilisation, contractual safeguards’ integration key for Indian exporters: ReportIndian exporters need to integrate intellectual property protection with FTAs, customs, compliance, contracts and supply chains before ente...
- He could have joined Tesla. Instead, this Bengaluru techie quit Toyota and Volvo to build electric tractors for farmersBengaluru startup Moonrider is developing electric tractors for Indian farmers. The company aims to replace diesel-powered machines with su...
- Pharma mutual funds top return charts across horizons. Should investors chase the rally or stay cautious?Pharma mutual funds are leading returns in CY2026, driven by strong earnings, defensive demand, and US export growth. Despite recent outper...
- Cipla in no hurry to launch semaglutide as Yurpeak gains tractionCipla is focusing on its tirzepatide brand Yurpeak in India's obesity market. Yurpeak has become the second largest GLP-1 product since its...
- 'I expect India to be concerned about US pharma tariffs': Rubio on Trump's 200% stormUS Secretary of State Marco Rubio anticipates Indian concern over new generic drug import tariffs. These tariffs will rise significantly af...
- Trump’s 100% generic drug duty threatens US low-cost supplyPresident Donald Trump has given generic drugmakers two years to shift manufacturing to the US or face 100% import tariffs from August 2028...
Load More
